GRP
CDTX

Global Retirement Partners’s Cidara Therapeutics CDTX Stock Holding History

Global Retirement Partners’s Portfolio CDTX Stock Details CDTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$45.3K Buy
+205
New +$33.1K ﹤0.01% 2412

Other funds holding CDTX

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JFG
Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return

Global Retirement Partners's CDTX Position: Q4 2025 in Review

Global Retirement Partners opened a new position in Cidara Therapeutics (CDTX) in Q4 2025: 205 shares worth $45.3K. The stake represents ﹤0.01% of the portfolio and ranks #2412 among its holdings.

255 funds tracked by Wall St. Rank hold CDTX as of Q4 2025.

  • Global Retirement Partners held 205 shares of Cidara Therapeutics worth $45.3K as of Q4 2025.
  • Cidara Therapeutics was a new Global Retirement Partners position in Q4 2025.
  • Cidara Therapeutics made up ﹤0.01% of Global Retirement Partners's portfolio in Q4 2025, its #2412 holding.
  • 255 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q4 2025.

Based on Global Retirement Partners's 13F filing for Q4 2025, filed 6 Feb 2026.